15 Results for "

54491

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "54491" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-101761
CAS No.: 1190221-43-2
Purity:  99.08%
Target:  

PAI-1 Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 (PAI-1), has IC50 values between 13.9 and 51.1 μM and induces intrinsic apoptosis in several human cancer cell lines. TM5441 attenuates Nω-nitro-l-arginine methyl ester-induced cardiac hypertension and vascular senescence .
2
2 Cited Publications
Cat. No.: HY-W008634
CAS No.: 56741-95-8
Synonyms: U-54461; U-54461S; PNU-54461
Research Areas:  

Cancer

Bropirimine (U-54461; U-54461S; PNU-54461) is an orally active TLR7 agonist. Bropirimine inhibits RANKL-induced osteoclast differentiation of mouse bone marrow-derived macrophages (BMMs). Bropirimine exhibits dose-dependent direct inhibitory effects on colony formation of cultured KK-47 and 724 cells. Bropirimine can be used for the study of cancers and bone metabolic disorders such as osteoporosis .
Cat. No.: HY-101761A
CAS No.: 2319722-53-5
Target:  

PAI-1 Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 (PAI-1), has IC50 values between 13.9 and 51.1 μM. TM5441 induces intrinsic apoptosis in several human cancer cell lines. TM5441 attenuates Nω-nitro-l-arginine methyl ester-induced cardiac hypertension and vascular senescence .
Cat. No.: HY-100963
CAS No.: 112465-94-8
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

U-54494A is a benzamide derivative related to κ-opioid receptor agonists, U-54494A has an anticonvulsant activity .
Cat. No.: HY-R01100
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-4491 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-182892
Research Areas:  

Cancer

MC4491 is a selective LSD1/PRMT5 inhibitor, with an IC50 of 0.152 μM against the LSD1/CoREST complex and an IC50 of 0.043 μM against the PRMT5/MEP50 complex. MC4491 induces transcriptomic changes and splicing alterations in AML cells. MC4491 is applicable for the research of acute myeloid leukemia .
Cat. No.: HY-101761R
CAS No.: 1190221-43-2
TM5441 (Standard) is the analytical standard of TM5441 (HY-101761). This product is intended for research and analytical applications. TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 (PAI-1), has IC50 values between 13.9 and 51.1 μM and induces intrinsic apoptosis in several human cancer cell lines. TM5441 attenuates Nω-nitro-l-arginine methyl ester-induced cardiac hypertension and vascular senescence .
Cat. No.: HY-R01100A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-4491 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI01100
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-4491 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
Cat. No.: HY-RI01100A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-4491 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-P85757
Synonyms: ACTN1

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Rat, Mouse

Cat. No.: HY-P85749
Synonyms: TF; Serotransferrin; Transferrin; Beta-1 metal-binding globulin; Siderophilin

Host:  

Mouse

Application:  

IHC-P, ICC/IF, ELISA

Reactivity:  

Human

Cat. No.: HY-P84794
Synonyms: CLEC4M; LSIGN; CD209L; L-SIGN; DCSIGNR; HP10347; DC-SIGN2; DC-SIGNR

Host:  

Mouse

Application:  

WB, FC, ELISA

Reactivity:  

Human

Cat. No.: HY-P85799
Synonyms: Estrogen receptor beta; ER-beta; Nuclear receptor subfamily 3 group A member 2;

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human

Cat. No.: HY-P84794A
Synonyms: CLEC4M; LSIGN; CD209L; L-SIGN; DCSIGNR; HP10347; DC-SIGN2; DC-SIGNR

Host:  

Mouse

Application:  

WB, FC, ELISA

Reactivity:  

Human

  • 1